ENDOBIOS biotech has a specialty expertise in the disruptive discovery of new bioactive natural products from marine-derived microorganisms (bacteria, fungi), and dereplication services – fast identification of valuable natural products in crude extracts.
Our currently most advanced project is the mid-preclinical trial development of a drug candidate isolated from a marine fungus, which is active against central nervous system disorders. Our main biodiscovery interests are new natural antibiotics and compounds active against neuropathies
ENDOBIOS biotech has a dual specialty expertise: the disruptive discovery and development of new bioactive natural products from marine microorganisms (bacteria, fungi), and the first-time biotechnological application related to endobacterial symbionts in the eukaryotic cytoplasm.
Besides custom services, ENDOBIOS also provides consulting in new natural products discovery and development (for Pharma, Agro or Cosmetic application),